{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T16:12:04Z","timestamp":1746634324235},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The aim was to evaluate S100A4 protein as a biomarker of disease activity and potential cancer development in patients with myositis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Serum levels of S100A4 were determined in 43 dermatomyositis (DM), 39 polymyositis (PM) and 22 cancer associated myositis (CAM) patients as well as in 77 healthy controls. The associations between S100A4 levels, inflammation, disease activity, muscle strength and cancer development were evaluated.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>All myositis patients had significantly higher serum levels of S100A4 protein compared to healthy controls (median (IQR): 31.5 (17.4 to 59.5) versus 23.8 (14.5 to 33.7) ng\/ml, <jats:italic>P<\/jats:italic> &lt;0.05). In patients with PM, serum levels of S100A4 protein were significantly higher than in healthy controls (41.6 (24.2 to 123.1) versus 23.8 (14.5 to 33.7) ng\/ml; <jats:italic>P<\/jats:italic> &lt;0.001) as well as in patients with DM (26.7 (11.3 to 47.5) ng\/ml; <jats:italic>P<\/jats:italic> &lt;0.05). The levels of S100A4 were comparable between myositis with and without cancer. In all myositis patients, serum S100A4 levels correlated with MYOsitis disease ACTivity assessment (MYOACT) score (r = 0.34; <jats:italic>P<\/jats:italic> = 0.001), constitutional (r = 0.30; <jats:italic>P<\/jats:italic> = 0.003), pulmonary (r = 0.43; <jats:italic>P<\/jats:italic> = 0.0001) and extramuscular disease activity (r = 0.36; <jats:italic>P<\/jats:italic> = 0.0001), as well as with creatine phosphokinase (r = 0.27; <jats:italic>P<\/jats:italic> = 0.015) and lactate dehydrogenase (r = 0.37; <jats:italic>P<\/jats:italic> = 0.002) or c-reactive protein (CRP) levels (r = 0.24; <jats:italic>P<\/jats:italic> = 0.038). Multiple regression analysis showed significant association between S100A4 serum levels and extramuscular disease activity (\u03b2 = 0.552; <jats:italic>P<\/jats:italic> = 0.002) in PM patients and with MYOACT (\u03b2 = 0.557; <jats:italic>P<\/jats:italic> = 0.003) and CRP levels (\u03b2 = 0.391; <jats:italic>P<\/jats:italic> = 0.029) in DM patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Circulating levels of S100A4 are elevated in patients with myositis and associate with several disease activity parameters, particularly with extramuscular components. No relation between S100A4 levels and presence of cancer associated myositis was found.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0468-2","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T11:32:43Z","timestamp":1414495963000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies"],"prefix":"10.1186","volume":"16","author":[{"given":"Lenka","family":"Ple\u0161tilov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Andr\u00e9s Cerezo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Pecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"468_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R: Polymyositis and dermatomyositis. Lancet. 2003, 362: 971-982. 10.1016\/S0140-6736(03)14368-1.","journal-title":"Lancet"},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00002281-199811000-00008","volume":"10","author":"R Spiera","year":"1998","unstructured":"Spiera R, Kagen L: Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1998, 10: 556-561. 10.1097\/00002281-199811000-00008.","journal-title":"Curr Opin Rheumatol"},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001, 357: 96-100. 10.1016\/S0140-6736(00)03540-6.","journal-title":"Lancet"},{"key":"468_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Forbes A, Hall S, Dennett X, Giles G: Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001, 134: 1087-1095. 10.7326\/0003-4819-134-12-200106190-00008.","journal-title":"Ann Intern Med"},{"key":"468_CR5","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar2987","volume":"12","author":"YJ Chen","year":"2010","unstructured":"Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT: Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther. 2010, 12: R70-10.1186\/ar2987.","journal-title":"Arthritis Res Ther"},{"key":"468_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","volume":"9","author":"S Zampieri","year":"2010","unstructured":"Zampieri S, Valente M, Adami N, Biral D, Ghirardello A, Rampudda ME, Vecchiato M, Sarzo G, Corbianco S, Kern H, Carraro U, Bassetto F, Merigliano S, Doria A: Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev. 2010, 9: 449-453. 10.1016\/j.autrev.2009.12.005.","journal-title":"Autoimmun Rev"},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","volume":"13","author":"ZA Zahr","year":"2011","unstructured":"Zahr ZA, Baer AN: Malignancy in myositis. Curr Rheumatol Rep. 2011, 13: 208-215. 10.1007\/s11926-011-0169-7.","journal-title":"Curr Rheumatol Rep"},{"key":"468_CR8","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1101\/gad.3.7.1086","volume":"3","author":"A Ebralidze","year":"1989","unstructured":"Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, Revazova E, Lukanidin E: Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2 + -binding protein family. Genes Dev. 1989, 3: 1086-1093. 10.1101\/gad.3.7.1086.","journal-title":"Genes Dev"},{"key":"468_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001, 33: 637-668. 10.1016\/S1357-2725(01)00046-2.","journal-title":"Int J Biochem Cell Biol"},{"key":"468_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","volume":"176","author":"K Boye","year":"2010","unstructured":"Boye K, Maelandsmo GM: S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2010, 176: 528-535. 10.2353\/ajpath.2010.090526.","journal-title":"Am J Pathol"},{"key":"468_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/sj.bjc.6602613","volume":"92","author":"DM Helfman","year":"2005","unstructured":"Helfman DM, Kim EJ, Lukanidin E, Grigorian M: The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer. 2005, 92: 1955-1958. 10.1038\/sj.bjc.6602613.","journal-title":"Br J Cancer"},{"key":"468_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1593\/neo.121554","volume":"14","author":"J Klingelhofer","year":"2012","unstructured":"Klingelhofer J, Grum-Schwensen B, Beck MK, Knudsen RS, Grigorian M, Lukanidin E, Ambartsumian N: Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. Neoplasia. 2012, 14: 1260-1268.","journal-title":"Neoplasia"},{"key":"468_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.semcancer.2012.02.006","volume":"22","author":"E Lukanidin","year":"2012","unstructured":"Lukanidin E, Sleeman JP: Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol. 2012, 22: 216-225. 10.1016\/j.semcancer.2012.02.006.","journal-title":"Semin Cancer Biol"},{"key":"468_CR14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.18388\/abp.2012_2097","volume":"59","author":"L Wang","year":"2012","unstructured":"Wang L, Wang X, Liang Y, Diao X, Chen Q: S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Acta Biochim Pol. 2012, 59: 593-598.","journal-title":"Acta Biochim Pol"},{"key":"468_CR15","first-page":"1595","volume":"60","author":"PS Rudland","year":"2000","unstructured":"Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 2000, 60: 1595-1603.","journal-title":"Cancer Res"},{"key":"468_CR16","first-page":"2309","volume":"3","author":"K Takenaga","year":"1997","unstructured":"Takenaga K, Nakanishi H, Wada K, Suzuki M, Matsuzaki O, Matsuura A, Endo H: Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res. 1997, 3: 2309-2316.","journal-title":"Clin Cancer Res"},{"key":"468_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/156652408785747942","volume":"8","author":"M Grigorian","year":"2008","unstructured":"Grigorian M, Ambartsumian N, Lukanidin E: Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies. Curr Mol Med. 2008, 8: 492-496. 10.2174\/156652408785747942.","journal-title":"Curr Mol Med"},{"key":"468_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.22398","volume":"56","author":"J Klingelh\u00f6fer","year":"2007","unstructured":"Klingelh\u00f6fer J, Senolt L, Baslund B, Nielsen GH, Skibsh\u00f8j I, Pavelka K, Neidhart M, Gay S, Ambartsumian N, Hansen BS, Petersen J, Lukanidin E, Grigorian M: Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2007, 56: 779-789. 10.1002\/art.22398.","journal-title":"Arthritis Rheum"},{"key":"468_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jid.2009.206","volume":"130","author":"JR Zibert","year":"2010","unstructured":"Zibert JR, Skov L, Thyssen JP, Jacobsen GK, Grigorian M: Significance of the S100A4 protein in psoriasis. J Invest Dermatol. 2010, 130: 150-160. 10.1038\/jid.2009.206.","journal-title":"J Invest Dermatol"},{"key":"468_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/gut.2008.170779","volume":"58","author":"CS Boomershine","year":"2009","unstructured":"Boomershine CS, Chamberlain A, Kendall P, Afshar-Sharif AR, Huang H, Washington MK, Lawson WE, Thomas JW, Blackwell TS, Bhowmick NA: Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut. 2009, 58: 1267-1274. 10.1136\/gut.2008.170779.","journal-title":"Gut"},{"key":"468_CR21","doi-asserted-by":"publisher","first-page":"G457","DOI":"10.1152\/ajpgi.00351.2009","volume":"299","author":"MF Cunningham","year":"2010","unstructured":"Cunningham MF, Docherty NG, Burke JP, O'Connell PR: S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration. Am J Physiol Gastrointest Liver Physiol. 2010, 299: G457-G466. 10.1152\/ajpgi.00351.2009.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"468_CR22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/rheumatology\/ker218","volume":"50","author":"LA Cerezo","year":"2011","unstructured":"Cerezo LA, Kuncov\u00e1 K, Mann H, Tomc\u00edk M, Z\u00e1mecn\u00edk J, Lukanidin E, Neidhart M, Gay S, Grigorian M, Vencovsky J, Senolt L: The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2011, 50: 1766-1772. 10.1093\/rheumatology\/ker218.","journal-title":"Rheumatology (Oxford)"},{"key":"468_CR23","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/rheumatology\/kep316","volume":"48","author":"L Oslejskov\u00e1","year":"2009","unstructured":"Oslejskov\u00e1 L, Grigorian M, Hulejov\u00e1 H, Vencovsky J, Pavelka K, Klingelh\u00f6fer J, Gay S, Neidhart M, Brabcov\u00e1 H, Suchy D, Oslejskov\u00e1 L, Grigorian M, Hulejov\u00e1 H, Vencovsky J, Pavelka K, Klingelh\u00f6fer J, Gay S, Neidhart M, Brabcov\u00e1 H, Suchy D, Senolt L: Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology (Oxford). 2009, 48: 1590-1594. 10.1093\/rheumatology\/kep316.","journal-title":"Rheumatology (Oxford)"},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, 292: 344-347. 10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"468_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975, 292: 403-407. 10.1056\/NEJM197502202920807.","journal-title":"N Engl J Med"},{"key":"468_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F: International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004, 43: 49-54. 10.1093\/rheumatology\/keg427.","journal-title":"Rheumatology (Oxford)"},{"key":"468_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","volume":"46","author":"Z Betteridge","year":"2007","unstructured":"Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N: Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007, 46: 1005-1008. 10.1093\/rheumatology\/kem045.","journal-title":"Rheumatology (Oxford)"},{"key":"468_CR28","unstructured":"GraphPad Software [], [http:\/\/www.graphpad.com]"},{"key":"468_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"ZE Betteridge","year":"2011","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ: Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther. 2011, 13: 209-10.1186\/ar3275.","journal-title":"Arthritis Res Ther"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG: The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007, 66: 1345-1349. 10.1136\/ard.2006.068502.","journal-title":"Ann Rheum Dis"},{"key":"468_CR31","doi-asserted-by":"publisher","first-page":"41278","DOI":"10.1074\/jbc.M007058200","volume":"275","author":"V Novitskaya","year":"2000","unstructured":"Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E, Lukanidin E: Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem. 2000, 275: 41278-41286. 10.1074\/jbc.M007058200.","journal-title":"J Biol Chem"},{"key":"468_CR32","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/ard.2005.047704","volume":"65","author":"L Senolt","year":"2006","unstructured":"Senolt L, Grigorian M, Lukanidin E, Simmen B, Michel BA, Pavelka K, Gay RE, Gay S, Neidhart M: S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis. 2006, 65: 1645-1648. 10.1136\/ard.2005.047704.","journal-title":"Ann Rheum Dis"},{"key":"468_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","volume":"13","author":"E Katzap","year":"2011","unstructured":"Katzap E, Barilla-LaBarca ML, Marder G: Antisynthetase syndrome. Curr Rheumatol Rep. 2011, 13: 175-181. 10.1007\/s11926-011-0176-8.","journal-title":"Curr Rheumatol Rep"},{"key":"468_CR34","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/rheumatology\/keu031","volume":"53","author":"LA Cerezo","year":"2014","unstructured":"Cerezo LA, Remakova M, Tomcik M, Gay S, Neidhart M, Lukanidin E, Pavelka K, Grigorian M, Vencovsky J, Senolt L: The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford). 2014, 53: 1520-1526. 10.1093\/rheumatology\/keu031.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0468-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:24:26Z","timestamp":1728923066000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0468-2","relation":{},"ISSN":["1478-6354"],"issn-type":[{"type":"electronic","value":"1478-6354"}],"subject":[],"published":{"date-parts":[[2014,10,31]]},"assertion":[{"value":"17 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"468"}}